Evotec SE (EVO) Net Shares Issued and Repurchased (2009 - 2010)
Evotec SE (EVO) posted Net Shares Issued and Repurchased of -$132.93 for Q1 2010, up 99.8% sequentially from -$64911.3 in Q4 2009, and down 331.02% YoY from $57.54 in Q1 2009.
Evotec SE (EVO) Net Shares Issued and Repurchased (2009 - 2010) Analysis & Trends
Evotec SE has reported Net Shares Issued and Repurchased for 2 years, with the latest figure at -$132.93 in Q1 2010.
- Quarterly Net Shares Issued and Repurchased fell 331.02% year-over-year to -$132.93 in Q1 2010, while the trailing twelve-month figure through Sep 2010 was -$65044.3 (changed N/A YoY) and the FY2009 annual result came in at -$61377.8, changed N/A from the prior year.
- Net Shares Issued and Repurchased advanced to -$132.93 in Q1 2010 per EVO's latest filing, from -$64911.3 in the prior quarter.
- Over five years, Net Shares Issued and Repurchased peaked at $57.54 in Q1 2009 and troughed at -$64911.3 in Q4 2009.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Shares Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | - |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Evotec SE | 687.23 Mn | 686.75 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2010 | -132.93 |
| Mar 31, 2010 | -132.93 |
| Dec 31, 2009 | -64,911.33 |
| Dec 31, 2009 | -64,911.33 |
| Mar 31, 2009 | 57.54 |
| Mar 31, 2009 | 57.54 |